Responses
Ovarian cancer
2022-RA-1505-ESGO Ovarian cancer retrospective European (O’CaRE) observational study: analysis of first-line (1L) outcomes in patients with ovarian cancer (OC) stratified by number of risk factors for progression
Compose a Response to This Article
Other responses
No responses have been published for this article.